This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sungkyunkwan University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Dong Gil You in Autoimmune Disease Treatment
Introduction
Dong Gil You is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach focuses on utilizing stem cell-derived exosomes to enhance therapeutic efficiency.
Latest Patents
Dong Gil You holds a patent for a composition aimed at preventing or treating inflammatory macrophage-mediated autoimmune diseases. The patent, titled "Composition for preventing or treating inflammatory macrophage-mediated autoimmune disease comprising exosomes derived from stem cells that are surface-modified to target activated macrophages," describes a unique formulation that targets activated macrophages. This composition is designed to improve the treatment of various autoimmune diseases, including rheumatoid arthritis, by increasing therapeutic efficiency while minimizing side effects compared to conventional treatments.
Career Highlights
Dong Gil You is affiliated with Sungkyunkwan University, where he conducts research and develops innovative solutions for complex medical challenges. His work has garnered attention for its potential to revolutionize the treatment landscape for autoimmune diseases.
Collaborations
He collaborates with notable colleagues, including Jae Hyung Park and Gyeong Taek Lim, to further advance research in this critical area of medicine.
Conclusion
Dong Gil You's innovative contributions to the treatment of autoimmune diseases highlight the importance of research in developing effective therapies. His work exemplifies the potential of stem cell technology in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
